Whilst FLT uptake has been shown to increase during sunitinib withdrawal in patients with renal cell carcinoma and other solid malignancies, this was not correlated with post-treatment Ki-67 proliferation index (19). The gene discussed is MKI67; the disease is hereditary clear cell renal cell carcinoma.